Cyclization & Conjugation Building Blocks

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
CP07709 Fmoc-NH-(PEG)3-CH2CH2COOH 443.5 C24H29NO7
CP07710 Fmoc-NH-(PEG)4-CH2CH2COOH 487.54 C26H33NO8
CP07711 Fmoc-NH-(PEG)5-CH2CH2COOH 531.59 C28H37NO9
CP07712 Fmoc-NH-(PEG)6-CH2CH2COOH 575.65 C30H41NO10
CP07713 Fmoc-NH-(PEG)8-CH2CH2COOH 663.8 C34H49NO12
CP07714 Fmoc-NH-dPEG3-COOH 429.47 C23H27NO7
CP07719 Boc-NH-(PEG)6-CH2CH2COOH 453.62 C20H39NO10
CP07720 Boc-Acp(6)-ol 217.31 C11H23NO3
CP07801 DL-Lanthionine 208.24
CP07802 L-Lanthionine 208.24
CP07803 D-Lanthionine 208.24
CP08703 N-α-Allyloxycarbonyl-N-δ-Boc-D-ornithine dicyclohexylamine salt 497.7
CP08704 N-α-Allyloxycarbonyl-N-δ-Boc-L-ornithine dicyclohexylamine salt 497.7
CP08706 N-α-Boc-N-δ-allyloxycarbonyl-D-ornithine 316.4
CP08707 N-α-Boc-N-δ-allyloxycarbonyl-L-ornithine 316.4 C14H24N2O6
CP08708 N-α-Boc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-ornithine 396.5
CP08719 N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-D-ornithine 560.7
CP08720 N-α-Fmoc-N-δ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-ornithine 560.7
CP08801 D-Propargyl-cysteine 159.21
CP08802 L-Propargyl-cysteine 159.21